Patents by Inventor Elise A. Sudbeck

Elise A. Sudbeck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • JAK-3 inhibitors for treating allergic disorders
    Patent number: 6933300
    Abstract: Inhibitors of JAK3 kinase for the treatment of allergy, and others are described.
    Type: Grant
    Filed: April 23, 2002
    Date of Patent: August 23, 2005
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Ravi Malavia, Elise A. Sudbeck
  • Therapeutic compounds
    Publication number: 20040192711
    Abstract: The invention provides novel JAK-3 inhibitors that are useful for treating leukemia and lymphoma. The compounds are also useful to treat or prevent skin cancer, as well as sunburn and UVB-induced skin inflammation. In addition, the compounds of the present invention prevent the immunosuppressive effects of UVB radiation, and are useful to treat or prevent autoimmune diseases, inflammation, and transplant rejection. The invention also provides pharmaceutical compositions comprising compounds of the invention, as well as therapeutic methods for their use.
    Type: Application
    Filed: November 17, 2003
    Publication date: September 30, 2004
    Applicant: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Elise A. Sudbeck, Marina Cetkovic, Ravi Malaviya, Xing-Ping Liu
  • Dimethoxy quinazolines for treating diabetes
    Patent number: 6495556
    Abstract: The invention provides novel JAK-3 inhibitors that are useful for treating leukemia and lymphoma. The compounds are also useful to treat or prevent skin cancer, as well as sunburn and UVB-induced skin inflammation. In addition, the compounds of the present invention prevent the immunosuppressive effects of UVB radiation, and are useful to treat or prevent autoimmune diseases, inflammation, and transplant rejection. The invention also provides pharmaceutical compositions comprising compounds of the invention, as well as therapeutic methods for their use.
    Type: Grant
    Filed: March 19, 2001
    Date of Patent: December 17, 2002
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Elise A. Sudbeck, Marina Cetkovic, Ravi Malaviya, Xing-Ping Liu
  • JAK-3 inhibitors for treating allergic disorders
    Publication number: 20020165243
    Abstract: Inhibitors of JAK3 kinase for the treatment of allergy, and others are described.
    Type: Application
    Filed: April 23, 2002
    Publication date: November 7, 2002
    Applicant: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Ravi Malaviya, Elise A. Sudbeck
  • Therapeutic compounds
    Patent number: 6469013
    Abstract: The invention provides novel JAK-3 inhibitors that are useful for treating leukemia and lymphoma. The compounds are also useful to treat or prevent skin cancer, as well as sunburn and UVB-induced skin inflammation. In addition, the compounds of the present invention prevent the immunosuppressive effects of UVB radiation, and are useful to treat or prevent autoimmune diseases, inflammation, and transplant rejection. The invention also provides pharmaceutical compositions comprising compounds of the invention, as well as therapeutic methods for their use.
    Type: Grant
    Filed: May 16, 2001
    Date of Patent: October 22, 2002
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Elise A. Sudbeck, Marina Cetkovic, Ravi Malaviya, Xing-Ping Liu
  • JAK-3 inhibitors for treating allergic disorders
    Patent number: 6452005
    Abstract: Inhibitors of JAK3 kinase for the treatment of allergy inhibit mast cell degranulation an dmediator release.
    Type: Grant
    Filed: February 22, 2001
    Date of Patent: September 17, 2002
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Ravi Malaviya, Elise A. Sudbeck
  • JAK-3 inhibitors for treating allergic disorders
    Publication number: 20020055514
    Abstract: Inhibitors of JAK3 kinase for the treatment of allergy inhibit mast cell degranulation an dmediator release.
    Type: Application
    Filed: February 22, 2001
    Publication date: May 9, 2002
    Applicant: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Ravi Malaviya, Elise A. Sudbeck
  • Therapeutic compounds
    Publication number: 20020042513
    Abstract: The invention provides novel JAK-3 inhibitors that are useful for treating leukemia and lymphoma. The compounds are also useful to treat or prevent skin cancer, as well as sunburn and UVB-induced skin inflammation. In addition, the compounds of the present invention prevent the immunosuppressive effects of UVB radiation, and are useful to treat or prevent autoimmune diseases, inflammation, and transplant rejection. The invention also provides pharmaceutical compositions comprising compounds of the invention, as well as therapeutic methods for their use.
    Type: Application
    Filed: May 16, 2001
    Publication date: April 11, 2002
    Applicant: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Elise A. Sudbeck, Marina Cetkovic, Ravi Malaviya, Xing-Ping Liu
  • JAK-3 inhibitors for treating allergic disorders
    Patent number: 6326373
    Abstract: Inhibitors of JAK3 kinase for the treatment of allergy inhibit mast cell degranulation an dmediator release.
    Type: Grant
    Filed: October 16, 2000
    Date of Patent: December 4, 2001
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Ravi Malavia, Elise A. Sudbeck
  • Dimethoxy quinazolines for treating diabetes
    Publication number: 20010044442
    Abstract: The invention provides novel JAK-3 inhibitors that are useful for treating leukemia and lymphoma. The compounds are also useful to treat or prevent skin cancer, as well as sunburn and UVB-induced skin inflammation. In addition, the compounds of the present invention prevent the immunosuppressive effects of UVB radiation, and are useful to treat or prevent autoimmune diseases, inflammation, and transplant rejection. The invention also provides pharmaceutical compositions comprising compounds of the invention, as well as therapeutic methods for their use.
    Type: Application
    Filed: March 19, 2001
    Publication date: November 22, 2001
    Applicant: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Elise A. Sudbeck, Marina Cetkovic, Ravi Malaviya, Xing-Ping Liu
  • JAK-3 inhibitors for treating allergic disorders
    Patent number: 6313130
    Abstract: Inhibitors of JAK3 kinase for the treatment of allergy inhibit mast cell degranulation an dmediator release.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: November 6, 2001
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Ravi Malaviya, Elise A. Sudbeck
  • Therapeutic compounds
    Patent number: 6313129
    Abstract: The invention provides novel JAK-3 inhibitors that are useful for treating leukemia and lymphoma. The compounds are also useful to treat or prevent skin cancer, as well as sunburn and UVB-induced skin inflammation. In addition, the compounds of the present invention prevent the immunosuppressive effects of UVB radiation, and are useful to treat or prevent autoimmune diseases, inflammation, and transplant rejection. The invention also provides pharmaceutical compositions comprising compounds of the invention, as well as therapeutic methods for their use.
    Type: Grant
    Filed: August 20, 1999
    Date of Patent: November 6, 2001
    Assignee: Hughes Institute
    Inventors: Fatih M. Uckun, Elise A. Sudbeck, Marina Cetkovic, Ravi Malaviya, Xing-Ping Liu
  • JAK-3 inhibitors for treating allergic disorders
    Patent number: 6177433
    Abstract: Inhibitors of JAK3 kinase for the treatment of allergy inhibit mast cell degranulation an dmediator release.
    Type: Grant
    Filed: November 19, 1999
    Date of Patent: January 23, 2001
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Ravi Malavia, Elise A. Sudbeck
  • JAK-3 inhibitors for treating allergic disorders
    Patent number: 6080747
    Abstract: Inhibitors of JAK3 kinase for the treatment of allergy inhibit mast cell degranulation an dmediator release.
    Type: Grant
    Filed: March 5, 1999
    Date of Patent: June 27, 2000
    Assignee: Hughes Institute
    Inventors: Fatih M. Uckun, Ravi Malavia, Elise A. Sudbeck
  • Therapeutic use of JAK-3 inhibitors
    Patent number: 6080748
    Abstract: Inhibitors of JAK3 kinase for the treatment of allergy inhibit mast cell degranulation an dmediator release.
    Type: Grant
    Filed: July 26, 1999
    Date of Patent: June 27, 2000
    Assignee: Parker Hughes Institute
    Inventors: Fatih M. Uckun, Ravi Malavia, Elise A. Sudbeck